CIN 2/3 and Cervical Cancer after an ASCUS Pap Smear: A 7-Year, Prospective Study of the Norwegian Population-Based, Coordinated Screening Program

Acta Cytologica

Volumn 47, Issue 6, 2003, Pages 991-1000

  Nygård, Jan F ^a   Sauer, Torill ^b   Skjeldestad, Finn Egil ^c   Skare, Gry Baadstrand ^a   Thoresen, Steinar Østerboø ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

ASCUS; Cervical cancer; Mass screening; Papanicolaou smear

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POPULATION RESEARCH; PRIORITY JOURNAL; TISSUE SECTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 0345327672     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326673     Document Type: Article

References (45)

1. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses: National Cancer Institute Workshop. JAMA 1989;262:931-934.
2. Abu-Jawdeh GM, Trawinski G, Wang HH: Histocytological study of squamous atypia on Pap smears. Mod Pathol 1994;7:920-924
3. Howell LP, Davis RL: Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Diagn Cytopathol 1996;14:20-24
4. Yang M, Zachariah S: ASCUS on cervical cytologic smears: Clinical significance. J Reprod Med 1997;42:329-331
5. Auger M, Charbonneau M, Arseneau J: Atypical squamous cells of undetermined significance: A cytohistologic study of 52 cases. Acta Cytol 1997;41:1671-1675
6. Ghoussoub RA, Rimm DL: Degree of dysplasia following diagnosis of atypical squamous cells of undetermined significance is influenced by patient history and type of follow-up. Diagn Cytopathol 1997;17:14-19
7. Williams ML, Rimm DL, Pedigo MA, Frable WJ: Atypical squamous cells of undetermined significance: Correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 1997;16:1-7
8. Nyirjesy I, Billingsley FS, Forman MR: Evaluation of atypical and low-grade cervical cytology in private practice. Obstet Gynecol 1998;92:601-607
9. Raab SS, Bishop NS, Zaleski MS: Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance. Gynecol Oncol 1999;74:460-464
10. Eltabbakh GH, Lipman JN, Mount SL, Morgan A: Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears. Gynecol Oncol 2000;79:44-49
11. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A: Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear. Acta Cytol 2000;44:576-586
12. Sheils LA, Wilbur DC: Atypical squamous cells of undetermined significance: Stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. Acta Cytol 1997;41:1065-1072
13. Alanen KW, Elit LM, Molinaro PA, McLachlin CM: Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Cancer 1998;84:5-10
14. Massad LS, Collins YC, Meyer PM: Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 2001;82:516-522
15. Lousuebsakul V, Knutsen SM, Singh PN, Gram IT: Variables associated with squamous intraepithelial lesions among women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Analyt Quant Cytol Histol 2001;23:355-361
16. Raab SS, Bishop NS, Zaleski MS: Long-term outcome and relative risk in women with atypical squamous cells of undetermined significance. Am J Clin Pathol 1999;112:57-62
17. Emerson RE, Puzanov A, Brunnemer C, Younger C, Cramer H: Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS). Diagn Cytopathol 2002;27:153-157
18. Östör AG: Natural history of cervical intraepithelial neoplasia: A critical review. Int J Gynecol Pathol 1993;12:186-192
19. Holowaty P, Miller AB, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-258
20. Kiviat N: Natural history of cervical neoplasia: Overview and update. Am J Obstet Gynecol 1996;175:1099-1104
21. Melnikov J, Nuovo J, Willan AR, Chan BKS, Howell LP: Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;92:727-735
22. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB: Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-1171
23. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129
24. Nygård JF, Skare GB, Thoresen SO: The cervical cancer screening programme in Norway, 1992-2000. J Med Screen 2002;9:86-91
25. Côté RA: Systematized nomenclature of medicine (SNOMED). Skokie, Illinois, College of American Pathologists, 1979
26. Royston P: Flexible parametric alternatives to the Cox model, and more. Stata J 2001;1:1-28
27. Royston P, Parmar MK: Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-2197
28. Aikake H: A new look at the statistical model identification. IEEE Trans Autom Control 1974;AC-19:716-723
29. Grambsch PM, Therneau TM: Proportional hazard tests and diagnostics based on weighted residuals. Biometrica 1994;81:515-526
30. Fahey MT, Irwig L, Macaskill P: Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-689
31. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819
32. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS: Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001;357:1831-1836
33. Sherman ME, Kelly D: High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: Screening failures or rapid progression? Mod Pathol 1992;5:337-342
34. Kibur M, Koskela P, Dillner J, Leinikki P, Saikku P, Lehtinen M, Hakama M: Seropositivity to multiple sexually transmitted infections is not common. Sex Transm Dis 2000;27:425-430
35. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study. Lancet 2000;355:2194-2198
36. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J: Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-1638
37. Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, de Schipper FA, Meijer CJ: HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001;85:398-404
38. Hughes SA, Sun D, Gibson C, Bellerose B, Rushing L, Chen H, Harlow BL, Genest DR, Sheets EE, Crum CP: Managing atypical squamous cells of undetermined significance (ASCUS): Human papillomavirus testing, ASCUS subtyping, or follow-up cytology? Am J Obstet Gynecol 2002;186:396-403
39. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
40. Vassilakos P, Cossali D, Albe X, Alonso L, Hohener R, Puget E: Efficacy of monolayer preparations for cervical cytology: Emphasis on suboptimal specimens. Acta Cytol 1996;40:496-500
41. Lerma E, Colomo L, Carreras A, Esteva E, Quilez M, Prat J: Rescreening of atypical cervicovaginal smears using PAPNET. Cancer 1998;84:361-365
42. Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, Woodward L: Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract 1998;46:136-141
43. Apgar BS, Brotzman G: HPV testing in the evaluation of the minimally abnormal Papanicolaou smear. Am Fam Physician 1999;59:2794-2801
44. Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A: Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral. Gynecol Oncol 2000;79:177-180
45. American Society of Cytopathology statement on new technologies in cervical cytology screening. June 2000. Analyt Quant Cytol Histol 2000;22:351